Published Date : Apr 01, 2016
In the gamut of pharmacologically active ingredients known for their efficacy, high potency active pharmaceutical ingredients (HPAPIs) are significant. This is because of reasons of significant efficiency and require a low dosage on an everyday basis due to their highly selective action mode. This efficiency of HPAPIs is promoted due to their ability to inhibit specific enzymes or bind to specific receptors.
Presently, HPAPI is the most swiftly developing segments in the pharmaceutical industry, which exhibits an astoundingly high growth rate. This is because of the high application rate of HPAPIs in the making of highly potent drugs and their ability to target disease cells accurately.
Some of the key trends observed in the HPAPI market are as follows:
Over the last decade, the number of individuals diagnosed with lifestyle diseases such as cancer has risen exponentially. This has been the reason for the exponentially increasing demand for high potency drugs. Thus, to cater to the increasing demand, top-notch pharmaceutical companies such as Roche, GSK, Pfizer, and Merck are focused on strengthening their pipelines with novel therapeutic drugs, mainly for cancer treatment.